MedTrace Logo

A Study To Evaluate The Difference In iPad-Based Cognitive Video Game (Akili Interactive's Project: EVO) Performance In Amyloid-Positive Versus Amyloid-Negative Healthy Elderly Volunteers

NCT02265718 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 97

Last updated 2019-06-05

No results posted yet for this study

Summary

The purpose of the study is to evaluate the difference in learning and performance measures associated with repeated use of an iPad video game (Akili Interactive's Project: EVO) in healthy elderly volunteers based on amyloid status.

Conditions

  • Healthy

Interventions

DRUG

Ritalin

1 - 20 mg tablet taken once on Day 0 and taken once on Day 28

DRUG

Placebo

1 - matching tablet taken once on Day 0 and once on Day 28

DRUG

Ritalin

1 - 20 mg tablet taken once on Day 0 and taken once on Day 28

DRUG

Placebo

1 - matching tablet taken once on Day 0 and once on Day 28

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
70 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02265718 on ClinicalTrials.gov